Development of Semisynthetic Saponin Immunostimulants

Overview

Journal Med Chem Res

Publisher Springer

Specialty Chemistry

Date 2024 Aug 12

PMID 39132259

Authors

Di Bai

Hyunjung Kim

Pengfei Wang

Affiliations

Soon will be listed here.

Abstract

Many natural saponins demonstrate immunostimulatory adjuvant activities, but they also have some inherent drawbacks that limit their clinical use. To overcome these limitations, extensive structure-activity-relationship (SAR) studies have been conducted. The SAR studies of QS-21 and related saponins reveal that their respective fatty side chains are crucial for potentiating a strong cellular immune response. Replacing the hydrolytically unstable ester side chain in the C28 oligosaccharide domain with an amide side chain in the same domain or in the C3 branched trisaccharide domain is a viable approach for generating robust semisynthetic saponin immunostimulants. Given the striking resemblance of natural saponins (MS) I and II to the deacylated (QS) saponins (e.g., QS-17, QS-18, and QS-21), incorporating an amide side chain into the more sustainable MS, instead of deacylated QS saponins, led to the discovery of MS-derived semisynthetic immunostimulatory adjuvants VSA-1 and VSA-2. This review focuses on the authors' previous work on SAR studies of QS and MS saponins.

References

Wang P, Devalankar D, Dai Q, Zhang P, Michalek S . Synthesis and Evaluation of QS-21-Based Immunoadjuvants with a Terminal-Functionalized Side Chain Incorporated in the West Wing Trisaccharide. J Org Chem. 2016; 81(20):9560-9566. PMC: 6488304. DOI: 10.1021/acs.joc.6b00922. View

Oda K, Matsuda H, Murakami T, Katayama S, Ohgitani T, Yoshikawa M . Adjuvant and haemolytic activities of 47 saponins derived from medicinal and food plants. Biol Chem. 2000; 381(1):67-74. DOI: 10.1515/BC.2000.009. View

Kim Y, LaFon D, Nahm M . Indirect Effects of Pneumococcal Conjugate Vaccines in National Immunization Programs for Children on Adult Pneumococcal Disease. Infect Chemother. 2016; 48(4):257-266. PMC: 5204004. DOI: 10.3947/ic.2016.48.4.257. View

ODonnell J, Isaacs A, Jakob V, Lebas C, Barnes J, Reading P . Characterization and comparison of novel adjuvants for a prefusion clamped MERS vaccine. Front Immunol. 2022; 13:976968. PMC: 9478912. DOI: 10.3389/fimmu.2022.976968. View

Di Pasquale A, Preiss S, Da Silva F, Garcon N . Vaccine Adjuvants: from 1920 to 2015 and Beyond. Vaccines (Basel). 2015; 3(2):320-43. PMC: 4494348. DOI: 10.3390/vaccines3020320. View

Thanvi R, Nada S, Dissanayake R, Vartak A, Sebilleau C, Alom N . Synthesis and Evaluation of a Self-Adjuvanting Pseudomonal Vaccine Based on Major Outer Membrane Porin OprF Epitopes Formulated with Low-Toxicity QS-21-Containing Liposomes. Bioconjug Chem. 2023; 34(5):893-910. PMC: 10723056. DOI: 10.1021/acs.bioconjchem.3c00103. View

Singleton K, Joffe A, Leitner W . Review: Current trends, challenges, and success stories in adjuvant research. Front Immunol. 2023; 14:1105655. PMC: 9892189. DOI: 10.3389/fimmu.2023.1105655. View

Pifferi C, Aguinagalde L, Ruiz-de-Angulo A, Sacristan N, Baschirotto P, Poveda A . Development of synthetic, self-adjuvanting, and self-assembling anticancer vaccines based on a minimal saponin adjuvant and the tumor-associated MUC1 antigen. Chem Sci. 2023; 14(13):3501-3513. PMC: 10055764. DOI: 10.1039/d2sc05639a. View

Reinke S, Thakur A, Gartlan C, Bezbradica J, Milicic A . Inflammasome-Mediated Immunogenicity of Clinical and Experimental Vaccine Adjuvants. Vaccines (Basel). 2020; 8(3). PMC: 7565252. DOI: 10.3390/vaccines8030554. View

10.

Luan N, Cao H, Wang Y, Lin K, Liu C . Ionizable Lipid Nanoparticles Enhanced the Synergistic Adjuvant Effect of CpG ODNs and QS21 in a Varicella Zoster Virus Glycoprotein E Subunit Vaccine. Pharmaceutics. 2022; 14(5). PMC: 9143440. DOI: 10.3390/pharmaceutics14050973. View

11.

Ahmed M, Farris E, Swanson R, Das S, Yang Y, Martin T . Saponin TQL1055 adjuvant-containing vaccine confers protection upon challenge in mice. Hum Vaccin Immunother. 2024; 20(1):2302070. PMC: 10793695. DOI: 10.1080/21645515.2024.2302070. View

12.

Kim H, Bai D, Ghosh S, Franks M, Wang X, Yan C . Structure-Activity Relationship Study of Saponin II Derivatives as Vaccine Adjuvants. J Med Chem. 2022; 65(21):14589-14598. PMC: 10202417. DOI: 10.1021/acs.jmedchem.2c01087. View

13.

Xiao C, Rajput Z, Liu D, Hu S . Enhancement of serological immune responses to foot-and-mouth disease vaccine by a supplement made of extract of cochinchina momordica seeds. Clin Vaccine Immunol. 2007; 14(12):1634-9. PMC: 2168389. DOI: 10.1128/CVI.00339-07. View

14.

Shen E, Rabe H, Luo L, Wang L, Wang Q, Yin J . Control of Germinal Center Localization and Lineage Stability of Follicular Regulatory T Cells by the Blimp1 Transcription Factor. Cell Rep. 2019; 29(7):1848-1861.e6. PMC: 6897316. DOI: 10.1016/j.celrep.2019.10.012. View

15.

Sun H, Zheng Q . Haemolytic activities and adjuvant effect of Gynostemma pentaphyllum saponins on the immune responses to ovalbumin in mice. Phytother Res. 2005; 19(10):895-900. DOI: 10.1002/ptr.1754. View

16.

Pink J, Kieny M . 4th meeting on Novel Adjuvants Currently in/close to Human Clinical Testing World Health Organization -- organisation Mondiale de la Santé Fondation Mérieux, Annecy, France, 23-25, June 2003. Vaccine. 2004; 22(17-18):2097-102. DOI: 10.1016/j.vaccine.2004.01.021. View

17.

Marcian D, Ptak R, Voss T, Reynolds R, Pathak A, Chamblin T . Degradation of Quillaja saponaria Molina saponins: loss of the protective effects of a herpes simplex virus 1 subunit vaccine. Int Immunopharmacol. 2002; 2(12):1703-11. DOI: 10.1016/s1567-5769(02)00192-3. View

18.

Carmen J, Shrivastava S, Lu Z, Anderson A, Morrison E, Sankhala R . SARS-CoV-2 ferritin nanoparticle vaccine induces robust innate immune activity driving polyfunctional spike-specific T cell responses. NPJ Vaccines. 2021; 6(1):151. PMC: 8668928. DOI: 10.1038/s41541-021-00414-4. View

19.

Shen L, Luo H, Fan L, Tian X, Tang A, Wu X . Potential Immunoregulatory Mechanism of Plant Saponins: A Review. Molecules. 2024; 29(1). PMC: 10780299. DOI: 10.3390/molecules29010113. View

20.

Ludwig G, Garcia-Garcia S, Lanaspa M, Ciruela P, Esteva C, Fernandez de Sevilla M . Serotype and clonal distribution dynamics of invasive pneumococcal strains after PCV13 introduction (2011-2016): Surveillance data from 23 sites in Catalonia, Spain. PLoS One. 2020; 15(2):e0228612. PMC: 7004304. DOI: 10.1371/journal.pone.0228612. View